National Academy of Medicine Calls for Integrated FDA-CMS Pathway for Biomarker Tests March 11, 2016Vol.42 No.10By Conor Hale
CMS Experiment Targets Incentive to Use the Most Expensive Drug March 11, 2016Vol.42 No.10By Paul Goldberg and Matthew Bin Han Ong
In Brief Tufts Medical Center and New England Cancer Specialists form affiliation March 11, 2016Vol.42 No.10
In Brief Baylor College of Medicine and Baylor Scott & White Health enter collaboration March 11, 2016Vol.42 No.10
Drugs & Targets NanoString Technologies and Merck to collaborate on Keytruda assay March 04, 2016Vol.42 No.09
Drugs & Targets Merck KGaA, Pfizer and Verastem enter into avelumab research agreement March 04, 2016Vol.42 No.09
Drugs & Targets FDA and EMA grant orphan designations to FLAG-003 for glioma March 04, 2016Vol.42 No.09
